Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.

Authors:
Chau I; Le DT; Ott PA; Korytowsky B; Le H and 8 more

Journal:
Gastric Cancer

Publication Year: 2020

DOI:
10.1007/s10120-019-01021-y

PMCID:
PMC6942567

PMID:
31679092

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gastric Cancer

Abbreviation: Gastric Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metas…
Kang YK; Ryu MH; Di Bartolomeo M and 15 more (2024) - Transparency Score: 4/6
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6.
Zhang X; He Y; Zhang X and 15 more (2024) - Transparency Score: 3/6
Artificial intelligence-guided discovery of gastric cancer continuum.
Vo D; Ghosh P; Sahoo D. (2023) - Transparency Score: 4/6
Circulating hormones and risk of gastric cancer by subsite in three cohort studies.
Sanikini H; Biessy C; Rinaldi S and 12 more (2023) - Transparency Score: 3/6
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.
Caspers IA; Biesma HD; Wiklund K and 11 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025